Intercept pulls liver disease drug from market as FDA puts clinical trials on hold

Intercept Pharmaceuticals said it is withdrawing Ocaliva from the US market, following a request from the FDA. The FDA also put a hold on all clinical trials involving Ocaliva, otherwise known as obeticholic acid, the ...